">

Tag: Novartis

Novartis launches malaria formulation Coartem 80/480

Novartis has launched a new antimalarial formulation of Coartem® 80/480 (artemether/lumefantrine 80 mg/480 mg), for the treatment of uncomplicated malaria in adults and older children, designed to reduce number of tablets taken per dose.  Created in a bid to enhance patient compliance, the full course of treatment for malaria has ...

Login to your account below

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.

Retrieve your password

Please enter your username or email address to reset your password.